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Tri-phasic CTAbstract Objective: To evaluate the efficacy of color Doppler US and tri-phasic CT in discriminat-
ing benign from malignant PVT. Patients and methods: This study included 30 patients presented
ultrasonically with PVT and referred for color Doppler US and Tri-phasic CT examination for
discriminating the benign from malignant PVT. The color Doppler US and tri-phasic CT results
were compared and correlated with available histopathological results in the patients who had
FNAC. Results: Those 30 patients were classified according to US, Tri-phasic CT, lab., findings
into two groups: G.(A) included 16 patients with malignant PVT and G.(B) included 14 patients
with benign PVT. Intrathrombus pulsatile flow was depicted in 12 patients with malignant PVT
(12/16) (75%), while non-depicted in 14 patients with benign PVT with 100% specificity. On tri-
phasic CT, neovascularity and an early arterial enhancement of PVT were depicted in 14 cases with
malignant PVT with 87.5% sensitivity and non-depicted in 14 benign cases with PVT with 100%
specificity. Conclusion:Distinguishing benign from malignant PVT in patients with HCC is required
to determine the management plan. The color Doppler study of PVT should be an essential step in
evaluation of patients with HCC. The combination of Color Doppler US and tri-phasic CT is com-
mon and essential for more accurate evaluation and differentiation of benign from malignant PVT.
 2015 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Portal vein thrombosis (PVT) is exactly what its name implies:
thrombosis of the portal vein and/or its tributaries, which
include the splenic vein and the superior mesenteric veins.
The thrombosis can occur within the main portal vein or in
the branches of portal vein within the liver itself. It can be
occluding or non-occluding thrombus with clot present but
with continued blood flow through the vessel. The sequel of
Table 2 Triphasic CT findings of G.(A) 16 patients with
malignant PVT.
Triphasic CT findings No. of
patients
%
PVT triphasic CT characteristics
(i) Neovascularity of thrombus 14 87.5
(ii) Arterial enhancement with rapid washout 14 87.5
(iii) Direct invasion by adjacent hepatic mass 12 75
(iv) Diameter of thrombus (>23 mm) 12 75
Hepatic focal lesion triphasic CT characteristics
Solitary 2 12.5
Multicentric 14 87.5
An early arterial enhancement with rapid
washout
16 100
848 A.H. Teama et al.a long-standing PVT is cavernous formation of the portal vein,
which represents bridging collateral around the occlusion (1).
PVT is usually a complication of pre-existing cirrhosis,
abdominal malignancy (e.g., pancreatic or HCC), hypercoagu-
lative states or abdominal inflammation (e.g., appendicitis,
diverticulitis, or pancreatitis) (2). Patients with cirrhosis and
early HCC may develop either benign or malignant PVT (3).
Distinguishing between benign and malignant PVT may be
required not only to determine its cause but also to detect
patients with HCC for liver transplantation, because tumoral
vascular invasion is an exclusion criterion for this procedure
(4). HCC invasion into PV renders a patient unsuitable for
aggressive treatment approaches such as surgical resection,
orthotopic liver transplantation or chemoembolization, due
to the unusually high incidence of tumor recurrence and dismal
survival associated with this finding (5).
Embolic forms of liver directed therapy for HCC such as
Trans Arterial Embolization (TAE) or Trans Arterial Chemo
Embolization (TACE) are relatively contraindicated in HCC
patient with PVT due to embolic effect on the hepatic artery,
leaving the PV as the sole source of blood supply to the liver.
If this supply is compromised, such as in the presence of PVT
(malignant or bland) or tumor compression, ischemic necrosis
becomes a possibility (6).
It is important to differentiate between benign and
malignant PVT to determine the management plan (7). It is
important to remember that most hepatic vascular disorders
are often not suspected clinically and are only diagnosed by
imaging studies due to non-specific clinical and laboratory
abnormalities associated with most hepatic vascular lesions
(8). PVT can be demonstrated by different imaging modalitiesTable 1 Real-time and color Doppler US findings in the 16
patients with malignant PVT of our study.
US findings No. of
patients
%
(A) Real-time US findings
Liver cirrhosis
Present 16 100
Absent – –
Hepatic mass
Multicentric 14 87.5
Single 2 12.5
Hypoechoic 10 62.5
Hyperechoic 2 12.5
Heterogeneous 4 25
Spleen
Splenomegaly 14 87.5
No splenomegaly 2 12.5
Ascites
Absent 2 12.5
Mild 6 37.5
Moderate 6 37.5
Marked 2 12.5
(B) Color Doppler US findings
(i) Pulsatile flow within thrombus 12 75
(ii) Nondetectable pulsatile flow within
thrombus
4 25such as real time US, color Doppler US, tri-phasic CT.,
MR., and MRA (9).
Abdominal US is a rapid and non-invasive technique for
investigation of the patients with suspected chronic liver dis-
ease, in addition to measurements of liver, splenic size and tex-
ture, and the detection of ascites determined by standard US
assessment (10). Sonogram usually shows the PVT as an echo-
genic lesion within the lumen of the portal vein (PV). However
clots exhibit variable echogenicity and may be hypoechoic or
anechoic (if recently formed). Conversely patent vessels mayTable 3 US findings of G.(B) 14 patients with benign PVT of
our study.
US findings No. of
patients
%
(A) Real-time US findings
Liver echotexture
Cirrhosis 10 71.4
Mixed cirrhosis and PPF 2 14.3
Enlarged bright liver 2 14.3
Hepatic focal lesion
Single 4 28.6
Multicentric – –
Hypoechoic – –
Hyperechoic 2 14.3
Heterogeneous 2 14.3
Spleen
Splenomegaly 8 57.1
No splenomegaly 42 8.6
Splenectomy 2 14.3
Ascites
Absent 8 57.1
Mild 4 28.6
Moderate 1 7.1
Marked 1 7.1
(B) Color Doppler US findings
(i) Non-detectable intrathrombus flow 8 57.1
(ii) Monophasic (stream) flow in non-
thrombosed part of PV
6 42.9
Table 4 Tri-phasic CT findings in G.(A) 14 patients with
benign PVT of our study.
Tri-phasic CT findings No of
patients
%
Liver
Normal CT pattern 4 28.6%
Cirrhotic 10 71.4%
Mixed cirrhosis and PPF 2 14.2%
Focal hepatic lesions (in only 4 patients) Single
in all 4 patients with an early arterial
enhancement with rapid washout (kinetic of
HCC)
4 28.6%
PVT
Neovascularity 0 0
Enhancement 0 0
Direct invasion by hepatic focal lesion 0 0
Increased diameter of thrombosed PV
(P23 mm)
0 0
Color Doppler US and tri-phasic CT 849show increased intraluminal echogenicity because of artifact or
erythrocyte rouleaux formation. By itself therefore increased
or decreased echogenicity in the lumen of PV is not sufficient
to either diagnose or exclude PVT (11).Table 5 Sensitivity and specificity of color Doppler US in diagnosi
Color Doppler US finding No of patients
Histopatholog./lab
G.(A) malig. G.(B) ben
Intrathrombus arterial pulsatile flow detection by Doppler US
(i) Detectable 12 0
(ii) Non-detectable 4 14
Total no. 16 14
Table 6 Triphasic CT sensitivity, specificity and accuracy in diagnos
histopathological results.
Triphasic CT finding (parameter) No. of patients
Histopatholog./lab.
G.(A) malig. G.(B) ben
Neovascularization of thrombus
(i) Detectable 14 0
(ii) Non-detectable 2 14
Arterial enhancem. of PV thrombus
(i) Detectable 14 0
(ii) Non-detectable 2 14
Thrombus invasion by tumor
(i) Detectable 12 0
(ii) Non-detectable 4 14
Thrombus diameter
P23 mm 12 0
<0.001 4 14Gray-scale imaging alone is inadequate for diagnosis of
PVT; therefore, the routine use of the color and spectral
Doppler is essential for all cases of PVT. PV obstruction is
demonstrated by Doppler US as accurately as angiography
provided Doppler is technically optimal (12). Because the
Doppler US is capable of accurately characterizing the nature
of flow within the PV, it is widely used for diagnosis of PVT.
However there are a variety of operator dependent technical
parameters (e.g., base-line, frame rate, wall filters, gain, veloc-
ity range, angle correction, gate size and position) that must be
optimized (13).
Tri-phasic CT is the best means of diagnosis of PVT and
evaluation of various causative disorders as well as the stage,
and the extension of thrombus (14). Tri-phasic CT. findings
of PVT are filling defect partially or totally occluding the vessel
lumen and rim enhancement of the vessel wall, sometimes with
extension into splenic and superior mesenteric veins (15). Un-
enhanced scans have been to be of minimal benefit in the iden-
tification of thrombus. Indirect signs of PVT are the presence
of cavernous transformation of PV (CTPV) and porto-
systemic collateral vessels (16).
Tri-phasic CT of the liver, using early, late arterial and
portal venous phases with fixed time delays is quick, easy
and non-invasive useful imaging modality in detection and
characterization of the focal lesions and especially the diagno-
sis of HCC in cirrhotic patients and non-invasively diagnosed
PVT and CTPV. In spite of the accuracy of tri-phasic CT scans of malignant PVT.
Sensitivity Specificity P value
ign
75% 100% <0.001
is of malignant PVT with statistical analysis in comparison with
Sensitivity (%) Specificity (%) P value
ign
87.5 100 <0.001
87.5 100 <0.001
75 100 <0.001
75 100 <0.001
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Fig. 1 (A–E) A male patient aged 45 YS, with final diagnosis of HCC and malignant PVT. (A) Color Doppler US of the main PV, Rt.
and Lt. PV branches revealed; Rt. and Lt. PV thrombus, with intrathrombus pulsatile flow (arterial waveforms) denoting neovascularity
of the thrombus, suggesting malignant nature of the thrombus. (B and C) Tri-phasic CT of the liver {arterial phase (B) and portal phase
(C)} revealed; Rt. Hepatic focal lesion (blue arrow) at VIII segment with rapid arterial enhancement and rapid washout at the portal phase
(kinetic behavior of HCC), also P.V. thrombus showed arterial enhancement with streak sign of neovascularity, with rapid washout in
portal phase and with exceeding its dimension >27 mm suggesting its malignant nature. (D) 2D coronal Portography revealed an evident
Rt. & Lt. PVT which confirmed through FNAC (E) to be malignant PVT.
850 A.H. Teama et al.in diagnosis of PVT, exposure to ionizing radiation and hyper-
sensitivity from injected contrast media remain major obstacle
compared to color Doppler US (17).
The use of Doppler US in diagnosis of malignant PVT has
been evaluated by several studies as non-visualization of portal
venous flow, pulsatile flow in the thrombus (18).
Combination of conventional MRI findings of HCC size of
more than 5 cm, distance from tumor to PVT of less than
2 cm, and arterial enhancement of PVT are useful in
differentiating malignant PVT from benign PVT. The sensitiv-
ity and specificity when two of these three criteria are present
are sufficiently high to obviate portal vein biopsy. Signal
intensity on DWI and ADC measurements cannot reliably
distinguish between malignant PVT and benign PVT in HCC
patients (19).
2. Patients and methods
This study was conducted on 30 patients selected from abdom-
inal Sonography survey which revealed PVT and referred to
Radio-diagnosis Department of National Liver Institute,Menoufia University for Color Doppler US, Tri-phasic CT
examination for specification the nature of thrombus and dis-
criminating benign from malignant PVT. This was performed
at the period from March 2014 to April 2015.
This study was approved by local research and ethical
Committee of International Liver Institute, Menoufia Univer-
sity. The aim, methods and limitation of technique were
described to every case before doing examination. No cost con-
cerning the radiological procedures was afforded upon any
patients.
Those patients were included in this study according to the
following criteria: Inclusion criteria: 1. Patients with chronic
hepatic disease and PVT who were candidate for liver trans-
plantation; and 2. patients with non-cirrhotic liver and pre-
sented with PVT.
Exclusion criteria: 1. Pregnant female patients to avoid
hazards of ionizing radiation to the fetus; 2. Contraindication
to the I.V. contrast agents such as severe allergic reaction, ter-
minal liver or renal failure (serum creatinine > 2 mg/dl); 3.
Hemodynamically unstable patients (e.g. the patients with per-
sistent hypotension unresponsive to fluid resuscitation); and 4.
C
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Fig. 2 (A–E) A male patient aged 43 YS, with final diagnosis of Lt. hepatic lobe HCC and malignant Lt. PV thrombosis. (A and B)
Color power Doppler US of hepatic vasculature revealed; Lt. PV thrombus with pulsatile flow denoting intrathrombus neovascularity
suggesting its malignant nature. Tri-phasic CT of the liver and its vasculature at an early arterial phase (C) and portal phase (D) revealed;
Lt. hepatic lobe focal lesion with corresponding regional bulging contour and with rapid arterial enhancement and rapid washout (kinetics
of HCC) + Lt. PV thrombosis with thread and streak sign, an early arterial enhancement with rapid washout in portal phase denoting
intrathrombus neovascularity. The diameter of thrombus measures 29 mm suggesting malignant nature. (D) 2D coronal portography
showing main trunk thrombosis extending to the Lt. PV which confirmed at FNAC to be malignant PVT.
Color Doppler US and tri-phasic CT 851Liver biopsy contraindication: increased prothrombin time or
international organized ratio (INR) > 1.6.
All patients of our study were subjected to the following:
1. Thorough history taking, with special emphasis on special
habits such as alcoholism, present history of hematemesis
or melena, jaundice, exposure or intake of hepatotoxic
drugs, previous local alcohol injection or any other local
ablation for hepatic focal lesion.
2. Clinical examination, including general examination stress-
ing on jaundice and the consciousness level and local
abdominal examination, with stressing on liver, spleen,
ascites and collaterals.
3. Laboratory investigations: including serum bilirubin, albu-
min, prothrombin activity. G.I. tumor markers including
serum alpha fetoprotein and anti-HBV and anti-HCV.
4. US examination:
a. Real-time US examination: with 3.5 MHz transducer
for examination of the liver as regards its size,
echotexture, contour, hepatic focal lesion, PV, presence
or absence of intrahepatic biliary radicle dilatation,
porta-hepatis, abdominal lymph nodes and ascites.
Also spleen, splenic hilum and pancreas were
evaluated.b. Color Doppler US examination of PV: *The protocol
consisted of obtaining gray-scale image of PV throm-
bus and performing color, power and duplex Doppler
US for PV thrombus, PV tributaries and branches to
determine thrombus distribution and also adjacent
hepatic artery.*Lt. PV thrombi were evaluated using
anterior subxiphoid approach. The main and Rt. PV
thrombi were evaluated using intercostal or subcostal
approach. *All PV thrombi were first evaluated by
color Doppler US for localization regions of flow
within the thrombi, followed by Duplex Doppler US
for characterization of detectable flow. *Doppler con-
trols were adjusted uniformly to maximum gain with-
out background noise, lowest pulse repetition
frequency, without aliasing and a 2–5 mm Doppler gait
was used. *The flow in the thrombus was categorized
by spectral configuration as pulsatile or continuous.
The results of each patient were recorded on standard-
ized individual worksheet.
5. Tri-phasic CT examination of PV with 2 D portography:
*Tri-phasic CT abdomen and pelvis was performed using 64
multi-row detector (Aquilion, Toshiba Medical Systems). *One
LL
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Fig. 3 (A–E) A male patient aged 48 YS, with multicentric HCC and malignant PVT. Color Doppler US of hepatic vasculature (A and
B) revealed; Lt. PV thrombosis with intrathrombus pulsatile flow denoting intrathrombus neovascularity. Tri-phasic CT (C) (arterial
phase) and (D) (portal phase) revealed; ascites with small scattered hepatic masses that enhance early with washout rapidly in portal phase,
in addition to the Lt. PVT with thread and streak signs of neovascularity and an early arterial enhancement denoting their neoplastic
nature, also the diameter of the thrombus measures 39 mm exhibiting CT pattern of malignant PVT (confirmed at FNAC to be malignant
PVT). (E) 2D portography showed complete PVT at the level of porta-hepatis.
852 A.H. Teama et al.hour before CT scanning the patients received 320 ml of dilute
barium orally (Scan C:2.1% weight by weight barium sulfate)
for gastrointestinal opacification. *Via automatic power
injector, 150 ml of Omnipaque 300 mg /ml. was injected I.V.
(4 ml/s). *Double arterial phase scanning consisting of early
and late arterial phase image acquisition was performed during
a single breath-hold using respectively, 20 and 35 s scanning
delays from initiation of contrast material injection. *We
elected to perform these two phases during a single breath-hold
to minimize the effect of variation on lesion conspicuity and
detection.
*The entire liver was scanned in a cephalocaudal
direction using detector collimation of 5 mm with a table
speed/rotation of 15 mm/0.8 s, and an image thickness of
5 mm.
*After a brief period of quiet breathing, portal venous
phase imaging of the entire abdomen during breath hold used
a scanning delay of 60 s. *The scanning parameters used were
120 kV and 150–250 mAs.
*Portography was done by 2D coronal reconstruction in
portal venous phase and MIP is the optimal technique for dis-
playing portography.
6. US guided fine needle aspiration cytology (FNAC) of PV
thrombus:*FNAC from thrombus was performed in only 20 patients
out of 30 ones of our study who were highly suspected to
have malignant PVT (based on elevated alpha fetoprotein,
US (pulsatile flow) and tri-phasic CT (intrathrombus neovas-
cularization, direct tumor invasion, early arterial thrombus
enhancement, increased dimension of PVT > 23 mm and adja-
cent HCC) characteristics, while remaining 10 cases who
showed normal values of tumor markers and alpha fetoprotein
with routine US and triphasic CT benign characteristics were
excluded from FNAC.
*All aspiration samples were taken from thrombi located in
the intrahepatic portion of PV. *Results of coagulation studies
were either normal or corrected. *FNAC was performed using
22 Gauge Chiba Needle under continuous color Doppler sono-
graphic guidance. *Local anesthetic (1% Lidocaine) was used
before each biopsy. *FNAC was achieved from thrombus that
was nearest to the hepatic mass and most suspicious ones on
color Doppler US = FNAC technique; *Gray scale localiza-
tion of an intrahepatic segment of thrombosed PV. *Color
Doppler localization of the adjacent hepatic artery and other
major vessels. *The choice of a biopsy path that was
trans-hepatic with avoidance of hepatic artery and other major
vessels. *Color Doppler US guidance of a biopsy needle with
stylet in place into the middle of the thrombus (N.B. we used
free hand method for all biopsies).
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Fig. 4 (A–E) A male patient aged 46 YS, with previous history of HCC and TACE coming for follow-up. (A) Gray-scale and (B) color
Doppler US of PV revealed Rt. PV hypoechoic thrombus (arrowed) without detectable intrathrombus neovascularity. Triphasic CT of the
liver and its hepatic vasculature (B) (arterial phase) and (C) (portal phase) revealed; hepatomegaly with small scattered hepatic focal
lesions with an early arterial enhancement and rapid washout in portal phase + Rt. PV. Thrombus (arrowed) which invaded by the tumor
(HCC) and the surrounding satellite nodules. (C) 2D coronal portography revealed non-visualization of the distal part of right branch,
and traces of lipidol (previous TACE) are noted.
Color Doppler US and tri-phasic CT 853*Removal of needle stylet and connection of syringe for
aspiration. *Aspiration as the needle was removed with care
taken to keep the needle within the lumen of PV.
*Cessation of aspiration and withdrawal of the needle. *The
patient held the breath during needle placement and aspira-
tion, with shallow breaths in between. *The histopathological
results of aspirated sample were recorded.
*All patients were monitored for 4 h after the biopsy and
then followed up to 24 h to detect and manage any complica-
tions such as hemorrhage and infection.
*The color Doppler US and tri-phasic CT findings of PVT
were compared and correlated with histopathological results
in the patients who had performed FNAC. *Statistical
presentation and analysis of this study were conducted using
Chi-square tests by SPSS V 17. The diagnostic accuracy of
color Doppler US and tri-phasic CT was compared with
histopathological results as standard for reference through
Chi-Square tests (p value < 0.05 is considered significant).
3. Results
This study was conducted on 30 patients who presented ultra-
sonically with PVT and referred to Radiodiagnosis Depart-
ment of National liver institute for color Doppler US and
tri-phasic CT to discriminate benign from malignant PVT.Color Doppler US and tri-phasic CT with portography of
PVT were performed for all 30 patients and also alpha fetopro-
tein and GI tumor markers were evaluated.
FNAC was selectively performed for only 20 patients who
were highly suspicious of malignant PVT {(based on elevated
alpha fetoprotein (>400 IU/ml), with US and tri-phasic CT
characteristics of malignant PVT & HCC}, while other 10
patients with normal alpha fetoprotein (<400 IU/ml) and with
routine US and tri-phasic characteristics of benign PVT, were
excluded from FNAC.
Out of 20 patients who had performed FNAC, 16 patients
(16/20) (75%) proved histopathologically to be malignant
PVT, while the remaining 4 patients showed benign PVT.
On US (real-time and color Doppler) examination of G.(A)
16 patients with malignant PVT, we found that all of them
showed liver cirrhosis (16/16) (100%), with multicentric hep-
atic mass in 14 patients (14/16) (87.5%) and solitary in the
other two ones, also pulsatile flow within the thrombus was
detected in 12 patients (12/16) (75%) as shown in Table 1.
On tri-phasic CT examination of the G.(A) 16 patients with
malignant PVT, we found that out of those 16 patients, 14
patients (14/16) (87.5%) showed neovascularity of the throm-
bus, with rapid enhancement in arterial phase and rapid wash-
out in portal phase, and 12 patients (12/16) (75%) showed
direct invasion of PV with adjacent hepatic mass and increased
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Fig. 5 (A–D) A male patient aged 48 YS, with benign Lt. PVT. (A) Color Doppler US revealed Lt. echogenic thrombus without
detectable intrathrombal neovascularity. Triphasic axial CT images {arterial phase (B) and portal phase (C)} revealed; Lt. PVT without
enhancement either in arterial or in portal phase (i.e. no internal neovascularity), and measured 17 mm at its dimension exhibiting CT
pattern of benign PVT. (D) 2D coronal portography revealed; non-visualized Lt. PV branch.
854 A.H. Teama et al.dimension of thrombus (>23 mm). All 16 patients showed
hepatic focal lesions {14 with multicentric (87.5%) and 2 with
single focal lesion (12.5%)} and all these focal lesions showed
an early arterial enhancement with rapid washout exhibiting
CT pattern of HCC (100%) as shown in Table 2.
On US examination (real-time and color Doppler) of the G.
(B) 14 patients with benign PVT we found that out of those 14
patients, 10 patients showed liver cirrhosis, 2 patients with
mixed cirrhosis and PPF, 2 patients had bright enlarged liver
and 4 patients had hepatic mass as shown in Table 3.
Out of 14 patients with benign PVT, 8 patient had not
intrathrombus flow (either stream or pulsatile flow) (8/14)
(57.1%), while the remaining 6 patients (6/14) (42.9%) showed
monophasic (stream) flow in the non-thrombosed part of the
PV (i.e. in partial PVT).
On triphasic CT of the G.(B) 14 patients with benign PVT,
we found that out of those 14 patients, 10 patients (10/14)
(71.4%) showed cirrhotic changes, 4 patients had hepatic focal
lesion (28.6%), 4 patients had normal liver (4/14) (28.5%), the
hepatic focal lesions in the 4 patients showed an early arterial
enhancement with rapid washout (kinetics of HCC). The 14
patients with benign PVT had not neovascularity or early arte-
rial enhancement of the thrombus or direct invasion of throm-
bus by tumor as shown in Table 4.
The sensitivity, specificity and accuracy of color Doppler
US in diagnosis of malignant PVT were calculated as shown
in Table 5.
From this table we found that intrathrombus pulsatile flow
was detectable in 12 patients out of 16 patients of G.(A) with
malignant PVT, with sensitivity of about 75%, while it was notdetectable in any one of 14 patients of G.(B) with benign PVT
with specificity (100%) and with accuracy of 86.7%.
The tri-phasic CT sensitivity and specificity in diagnosis of
malignant PVT were also calculated in comparison with the
histopathological results as shown in Table 6, Figs. 1–7.
According to neovascularization and arterial enhancement
tri-phasic CT parameters in diagnosis of malignant PVT, 14
patients out of 16 patients with malignant PVT were diagnosed
with sensitivity of 87.5%, specificity of 100% and accuracy of
93.3%, while according to thrombus invasion by tumor and
exceeding thrombus diameterP23 mm, 12 patients were diag-
nosed with sensitivity of 75%, specificity of 100% and accu-
racy of 86.7%.4. Discussion
Hepatocellular carcinoma (HCC) is the third leading cause of
cancer mortality worldwide. This malignancy occurs more
often among men than women, with highest incidence rates
reported in East Asia (20). This was in agreement with that
of our study in which out of 30 patients with PVT, 24 patients
were males (80%) and 6 patients were females (20%), with age
ranged from 41 to 75 YS and mean age 52.2 YS.
HCC invasion into the portal vein renders a patient unsuit-
able for aggressive treatment approaches such as surgical
resection, orthotopic liver transplantation, chemoemboliza-
tion, due to the unusually high incidence of tumor recurrence
and dismal survival associated with these findings (5). In our
study we found that all 16 patients with malignant PVT were
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Fig. 6 (A–F) A female patient aged 41 YS, with benign partial main PVT. Real-time (A) and color (B) and power (C) Doppler US of
main PV revealed; anterior wall partial mural thrombus with no evidence of internal vascularity, without detectable internal
neovascularity of the thrombosed part, with patent its posterior part. Tri-phasic axial CT {arterial phase (D) and portal phase (E)}
revealed; anterior partial mural thrombus measuring 11 mm at its dimension without detectable thrombal enhancement either in arterial
or in portal phase (i.e. without detectable neovascularity) exhibiting CT pattern of benign partial PVT. (F) 2D coronal portography
revealed main partial PVT.
Color Doppler US and tri-phasic CT 855suffering from HCC (100%) and tumor invasion of PV was
detectable in 12 patients out of 16 patients with malignant
PVT (75%).
The main pathogenic factor of PVT in cirrhosis is the obsta-
cle to portal flow, but acquired and inherited clotting abnor-
malities may play a role. The formation of collateral veins
allows many patients to remain asymptomatic and prevents
the onset of clinical complications also in patients with totally
occlusive PVT (21). In the current study the liver cirrhosis was
present in all 16 patients with malignant PVT (16/16) (100%)
and in 12 patients out of 14 patients with benign PVT
(12/14) (85.7%).
The diagnosis of PVT has become easier because of real
time sonography. However, the gray scale sonographic appear-
ance of the thrombus is not specific and cannot distinguish
benign from malignant thrombi. The use of color Doppler
US in the diagnosis of malignant PVT has been evaluated by
several studies as non-visualization of portal vein flow, pul-
satile flow in the thrombus (18).
In the study of Dodd et al. (13) they found that out of
47 patients with PVT, 26 patients were proved to be malig-
nant through CT and histopathological findings and 21
patients proved to be benign. Intrathrombus pulsatility was
detected in 16 patients with malignant PVT (16/26)
(61.5%) and only detected in 3 patients with benign PVT
(3/21) (14.3%). The pulsatile flow detected in the 3 patients
with benign PVT represented portal venous flow coursing
through the interslices of the thrombi. This was attributed
to arterial portal venous shunting which is a common
phenomenon in liver cirrhosis.In the study of Rossi et al. (22) they found that out of 83
patients with PVT, 81 patients were proved to be malignant
(81/83) (97.6%) on imaging and pathological basis and 2
patients proved to be benign (2/83) (2.4%). Pulsatility
within thrombus was detected in 51 patients with malignant
PVT (51/81) (63%) and non-detectable in the 2 patients with
benign PVT. Thus the sensitivity of color Doppler US for
detection of pulsatility in malignant PVT was 63% and with
100% specificity.
Mohamed (23) found that out of 32 patients of his study
with PVT, 15 patients were proved to be malignant PVT by
FNAC and 17 patients were benign. Out of 15 patients with
malignant PVT 13 patients showed intrathrombus pulsatile
flow (13/15) (86.7%), while the 17 patients with benign PVT
had no intrathrombus pulsatile flow on color Doppler US,
with 100% specificity.
In our study we found that out of those 30 patients with
PVT, 16 patients were proved to be malignant PVT through
FNAC (53.3%) and the remaining 14 patients were benign
PVT (46.7%). On color Doppler US we found that out of 16
patients with malignant PVT, 12 patients were having
intrathrombus arterial pulsatile flow (12/16) (75%), while the
14 patients with benign PVT had not intrathrombus pulsatile
flow, with 100% specificity. This was in agreement with results
of the study of Mohamed (23), Rossi et al. (22), and Tarantino
et al. (24) who stated that all patients with benign PVT had not
intrathrombus pulsatile flow with 100% specificity.
Tri-phasic CT is the best means of diagnosis of PVT and
evaluation of various causative disorders as well as the stage,
degree, and extension of the thrombus (14).
A B 
C D E
Fig. 7 (A–E) A male patient aged 59 YS, with main PVCT. Real-time US (A) and color Doppler US (B) of the porta-hepatis region
revealed; The main PV is non-visualized adequately, with partial thrombosis, regional and surrounding thin collateral vessels (exhibiting
US pattern of PVCT) without detectable intrathrombal neovascularity, suggesting its benign nature. Tri-phasic axial CT {arterial phase
(C) and portal phase (D)} revealed; chronic PVT without detectable thrombal enhancement either in arterial or in portal phase and with
small dimension (16 mm) denoting its benign nature. (E) 2D coronal portography revealed partial main PVT with regional traversing
small vessels and surrounding collaterals denoting cavernous transformation of the extrahepatic portion of the portal vein (PVCT).
856 A.H. Teama et al.The study of Lee et al. (25) included 47 patients with malig-
nant PVT and 11 patients with benign PVT. On CT they found
that out of 47 patients with malignant PVT, 15 patients with
direct extension of HCC into PV, 29 patients with PVT
adjacent to HCC and 3 patients with PVT remote from
HCC. The main diameters of malignant and benign PVT were
significantly different (23.4 versus 16 mm). Generalized
enhancement was detected in 39 patients out of 47 patients
with malignant PVT (39/47) (83%), while detected in only
two patients out of 11 patients with benign PVT (2/11)
(18%). Also neovascularity was detected in 20 patients with
malignant PVT (20/47) (42%), while it could not be detected
in any one of 11 patients with benign PVT. Identification of
a main PVT diameter >23 mm resulted in a sensitivity and
specificity of the CT characterization of malignant PVT of
86% and 100% respectively.
In the study of Piscalgia et al. (26) which was done on
33 patients who had HCC with PVT and came for liver
transplantation, 9 patients of them were not placed on the
transplantation list as 2 were diagnosed to have malignant
PVT simultaneously with HCC, while the other 7 ones were
removed from transplantation list as they developed malignant
PVT after diagnosis of HCC. The criteria that were considered
by the authors and on their basis malignant PVT is diagnosed
were intrathrombus vascularity observed in the arterial phase
on tri-phasic CT (has been reported to be a sign that is specific
for malignant PVT on CT) whereas, in contrast, a lack ofvascularization of the thrombus could be considered to imply
the benign nature of PVT.
In our study we found that on tri-phasic CT of 30 patients
of our study, out of 16 patients with malignant PVT, 14
patients showed neovascularity of PVT and an early arterial
enhancement and rapid washout of the thrombus (14/16)
(87.5%) and none of the 11 patients with benign PVT showed
intrathrombus neovascularity or enhancement. So tri-phasic
CT had sensitivity 87.5%, specificity 100% and accuracy
93.3% in characterizing malignant PVT. Our results were in
agreement with those of Lee et al. (25) and Psicalgia et al.
(26) who considered neovascularity sign is 100% specific for
malignant PVT. Also we found that out of 16 patients with
malignant PVT 12 patients showed PVT dimension
(>23 mm) with sensitivity 75%, specificity 100% and accuracy
86.6%. These results were nearly in agreement with Tublin
et al. (27) who reported 83% sensitivity and 81% specificity.
In the present study we found that out of 16 patients with
malignant PVT, 12 patients showed direct invasion of throm-
bus by HCC (75%) while this CT sign was not detectable in
any one of the 4 patients who had benign PVT associating
HCC with specificity of about 100%. This is matching with
that reported by Tublin et al. (27). Consequently, if a
neovascularity, thrombus enhancement, thrombus diameter
P23 mm, or direct invasion of the thrombus by tumor (either
alone or combined) was detected by CT then the specificity for
the diagnosis of malignant PVT approaches 100%.
Color Doppler US and tri-phasic CT 8575. Conclusions
Distinguishing benign (bland) from malignant (neoplastic)
PVT in patients with HCC is required to select the patients
suitable for liver transplantation as a malignant vascular
invasion is an exclusion criterion for this procedure. So this
differentiation is very important in planning strategy of
management.
Color Doppler study of the PVT should be an essential step
(non-invasive and cheap) in the evaluation of patients with
HCC associated with PVT during planning for their
management.
The specificity of intra-thrombal pulsatile flow for the diag-
nosis of malignant PVT approaches 100% if the character of
this flow is clearly different from that of the hepatic artery
and a patent segment of the PV.
The absence of intrathrombal flow does not exclude its
malignant nature and here comes the role of multidetector
triphasic CT that showed higher sensitivity (87.5%) and accu-
racy (93.3%) in comparison with the color Doppler US (with
sensitivity 75% and accuracy 86.7%) in detecting malignant
PVT.
Malignant and benign PVT can often be differentiated on
the basis of CT imaging characteristics (direct tumor invasion
into PV, intrathrombal neovascularity with an early arterial
phase enhancement, diameter of the thrombus P23 mm).
The combination of CT and color Doppler US is common
and essential for more accurate evaluation of PVT and differ-
entiation benign from malignant PVT.
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